Hisamitsu Pharmaceutical Co (TSE:4530) Other Operating Expense : 円65,803 Mil (TTM As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Other Operating Expense?

Hisamitsu Pharmaceutical Co's Other Operating Expense for the three months ended in Nov. 2023 was 円16,080 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2023 was 円65,803 Mil.

Hisamitsu Pharmaceutical Co's quarterly Other Operating Expense increased from May. 2023 (円14,356 Mil) to Aug. 2023 (円15,894 Mil) and increased from Aug. 2023 (円15,894 Mil) to Nov. 2023 (円16,080 Mil).

Hisamitsu Pharmaceutical Co's annual Other Operating Expense increased from Feb. 2022 (円60,730 Mil) to Feb. 2023 (円61,099 Mil) and increased from Feb. 2023 (円61,099 Mil) to Feb. 2024 (円65,803 Mil).

Hisamitsu Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Other Operating Expense Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Other Operating Expense

Get a 7-Day Free Trial

64,875.00

58,501.00

60,730.00

61,099.00

65,803.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Operating Expense	Get a 7-Day Free Trial															16,825.00	14,356.00	15,894.00	16,080.00	19,473.00

Hisamitsu Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円65,803 Mil.

Hisamitsu Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines